Q2 2020 Holdings
Filed 2020-08-14 | 16 holdings | $56.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $48.2M | 4,500,000 | 85.5% |
| Adaptimmune Therapeutics(ADAPY) | SPONS ADR | 00653A107 | $7.8M | 781,940 | 13.9% |
| Constellation Pharmaceuticals Inc(CNST) | COM | 210373106 | $120.7K | 4,016,873 | 0.2% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $54.9K | 6,790,000 | 0.1% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $29.9K | 668,440 | 0.1% |
| Surface Oncology Inc | COM | 86877M209 | $25.4K | 3,877,895 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $25.2K | 672,306 | 0.0% |
| Vaxart Inc(VXRT) | COM NEW | 92243A200 | $24.5K | 2,765,000 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $17.4K | 845,000 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $14.5K | 5,726,540 | 0.0% |
| Inari Medical Inc(NARIUSD) | COM | 45332Y109 | $11.4K | 235,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $9.4K | 575,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $9.3K | 625,710 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONS ADR | 05337M104 | $8.5K | 1,057,827 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $5.8K | 291,140 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $4.6K | 378,888 | 0.0% |